Regulatory Approval

As crypto markets fragment, WhiteBIT's new 'Crypto Bundles' offer simplified, index-style investing. But do these thematic baskets truly tame risk?

After an eight-year, community-led process, Webequie First Nation has secured approval for a supply road, setting a new precedent for self-determination.

At the University of Miami, 3D anatomical avatars are changing doctor visits. This tech promises clarity, but what are the hidden costs of progress?

NANO Nuclear's microreactor project enters formal NRC review, a pivotal step toward on-campus deployment and a new era of decentralized, clean nuclear power.

UpDoc just secured the first FDA clearance for a patient-facing clinical AI. This isn't just another app; it's a new paradigm for healthcare delivery.

A landmark FDA approval for Merck's KEYTRUDA and Gilead's Trodelvy creates a powerful new first-line treatment for advanced triple-negative breast cancer.

While NANO Nuclear pushes into emerging global markets, a sudden leadership change puts its CEO in direct control of its flagship microreactor project.

A new license for C-Ray Therapeutics is more than a permit; it's a key move in Beijing's strategy to dominate the high-stakes radiopharmaceutical market.

Trigon Pacific's proposal for a new LPG export facility is now open for public comment, highlighting a complex web of opportunity, competition, and conflict.

The $2B market for chronic hives is exploding, with new drugs from Sanofi, Celldex, and Novartis creating a seismic shift for patients and investors.

Less than two months after its IPO, Silver Bow Mining's fast-track to a major stock index spotlights the urgent quest for U.S. resource independence.

REPROCELL's submission for Stemchymal® offers hope for an incurable disease and highlights Japan's accelerated regulatory path for regenerative medicine.

Two of Michigan's oldest community banks are joining forces to create a $1.68B regional powerhouse. What will this mean for customers, employees, and the U.P.?

As data centers and AI push the U.S. grid to its limits, a proven Canadian reactor offers a path to energy security by sidestepping foreign fuel reliance.

With stringent approvals from Health Canada and South Korea's MFDS, a science-backed lemon verbena ingredient is set to reshape the sleep and stress market.

A creative $600M financing deal leverages Canadian tax policy to unlock a massive nickel supply for the EV industry, signaling a new era for green mining.

After game-changing FDA news for its Huntington's therapy, uniQure's upsized $225M offering signals massive investor confidence and accelerates its mission.

A novel drug designed by AI to prevent a crippling side effect of chemotherapy has received dual US and Taiwan regulatory approval, paving the way for human trials.

A Chinese tech firm just got the IMO's nod to turn ship exhaust into building materials. Is this the circular economy solution that finally decarbonizes the seas?

A new Quebec port terminal faces its final public review. Can legally binding conditions truly balance economic ambition with environmental realities?